SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Winkler who wrote (1508)2/11/1999 8:21:00 PM
From: scaram(o)uche   of 2135
 
David:

ENMD is a good company, doing legitimate and interesting research.

Dr. Folkman is a respected scientist who has championed a concept which should save gobbles of unnecessary suffering.

The malaria vaccine is a real shot at protection. It is work that is quite well known among those who follow biotech.

I don't personally give a damn if ENMD goes up or down tomorrow. But I do care about how the biotech sector is regarded by investors. There are many therapies that need funding going forward, and it is important that capitalizations do not become inconsistent with promise. You'll find similar comments from me and others, at appropriate moments, in the GERN thread.

Fortunately, this ranting game has gone on long enough that it looks like it is now only traders burning traders, that the widows and orphans are largely gone. A part of me would love to see ENMD hit 80 tomorrow so that some of those who were burned the first time could be "whole".

However..... A/E are laboratory curiosities, and ENMD is well behind in taking anti-angiogenesis to the clinic.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext